Omaha Doctor Sees Tremendous Success with Ivermectin as Early Treatment Against COVID-19

Physicians from around the United States continue to emerge, going public with their declaration of the benefits of ivermectin as an early onset, mild-to-moderate stage COVID-19 treatment. Most recently on KETV 7 Omaha, Dr. Louis Safranek came forth, declaring, “I typically use it in combination with other agents. But I do prescribe it for virtually all the patients who come to be, as part of a treatment regimen, which I think is effective for folks.” The Harvard Medical School graduate has been specializing in infectious diseases for four decades. Having treated nearly 200 COVID-19 patients at home and in the local hospitals here in Omaha, Nebraska, ivermectin is a key medicine tool in the medicine box targeting COVID-19.
TrialSite can assure that the National Institute of Health (NIH) formal policy in fighting the pandemic is to have a comprehensive mix of 1) safe and effective vaccines, 2) branded therapeutics, 3) generic repurposed therapeutics, and 4) sound and locationally relevant public health policy.

https://trialsitenews.com/omaha-doct...inst-covid-19/